Product Image

Full Spectrum Boswellia & Curcumin

Swanson Premium Brand
4.7
★ ★ ★ ★ ★
(1167 ratings)
Boswellia 300 mg
Turmeric 300 mg
Product Image
Score75
A simple boswellia-turmeric pairing offers good value and clear amounts. Unstandardized herbs and no absorption support limit potency confidence.
How scoring works
Quantity:60 Capsule(s) • (60 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 75

A simple boswellia-turmeric pairing offers good value and clear amounts. Unstandardized herbs and no absorption support limit potency confidence.
How scoring works

Also available as

1 option
Turmeric 400mg, Boswellia serrata 400mg, Tart Cherry 400mg • 60 Capsule(s) servings Boswellia 200 mg, Turmeric 200 mg • 60 Capsule(s) • 60 servings $10.19 ($0.16 per serving)
$11.09($0.18 per serving)
iHerb
$ 11.09
Amazon
$ 11.09
Report prices

Analysis

One capsule provides 300 mg boswellia serrata and 300 mg turmeric. The equal-weight formula is easy to understand and avoids a proprietary blend.

Boswellia and turmeric cover complementary inflammatory pathways, but neither lists boswellic-acid, AKBA, or curcuminoid content. Whole-herb amounts without absorption technology are less reliable than standardized extracts.

Sixty servings and a very low serving cost make it suitable for basic daily use. Buyers seeking stronger joint support should favor verified active markers rather than larger raw weights alone.

Who is it for
  • Adults seeking boswellia-turmeric capsules
  • Users who value clearly listed botanical weights
  • People who can screen herb-specific medication and tolerance concerns
Best for
  • Comparing botanical form and dose
  • Goal-aligned supplement selection
  • Users who prefer boswellia-turmeric capsules

Pros

  • Provides 300 mg of each botanical
  • One capsule per serving
  • Low cost per serving
  • No proprietary blend

Cons

  • No boswellic-acid percentage
  • No AKBA detail
  • No curcuminoid yield
  • No absorption enhancer

Warnings

  • Turmeric may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Turmeric can aggravate symptoms in people with gallstones or bile-duct obstruction
  • Stop use if the concentrated botanicals cause persistent nausea, reflux, or abdominal discomfort

Nutrient quality

65 Moderate impact

Boswellia and turmeric provide a focused pairing for joint comfort and inflammatory balance. Both are unstandardized powders with no absorption support.

.

Ingredient transparency

79 High impact

Individual ingredient weights make the formula broadly readable. Missing active-marker yields and non-active ingredient details reduce full transparency.

.

Customer satisfaction

74 High impact

The supplied rating is favorable and the feedback base is adequate. No complaint-level evidence was supplied to assess recurring issues or purpose-specific experiences.

.

Value for money

84 Highest impact

The serving cost is favorable for the amount of formula provided. Potency and standardization gaps still reduce certainty about effective value.

.
Report analysis

Goals

Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
High effect
A Goal FitD+ Strength of SupportC+ CoverageA+ Formula Quality
Boswellia · 300 mg

Boswellia and turmeric directly target complementary inflammatory signaling pathways. Their combination is strongly aligned with the goal, but neither ingredient is standardized to its key active compounds.

The total amounts are moderate for unstandardized powders and no absorption enhancer is included. Boswellia and turmeric may increase bleeding tendency with anticoagulant or antiplatelet medicines.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Joint Health
Impact
Moderate effect
B- Goal FitF Strength of SupportD- CoverageB+ Formula Quality
Boswellia · 300 mg

Boswellia and turmeric are relevant joint-comfort botanicals with complementary inflammatory targets. Their clinical value is uncertain here because neither ingredient is standardized and no absorption enhancer is identified.

The modest whole-herb amounts are unlikely to match well-studied extract doses. The pairing is logically coherent, but it favors broad label appeal over dependable active delivery.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
Boswellia serrata
300 mg
Turmeric
300 mg
Adults 18–50
Report overview
Boswellia · 300 mg OverallScore33
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyB- Value

The 300 mg Boswellia amount is clearly listed, but it appears to be unstandardized resin rather than a concentrated extract. No AKBA enrichment or absorption enhancer is identified, which limits confidence in active-compound delivery. The low cost is attractive, though the dose is modest for an unstandardized powder.

View ingredientView products
Turmeric · 300 mg OverallScore10
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyD- Value

The 300 mg turmeric portion is plain and has no stated curcuminoid strength. No absorption technology is included, so active delivery remains uncertain. The very low serving cost offers basic root-powder value rather than verified potency.

View ingredientView products
Loading alternative details
84 Performance

Boswellia Extract 500 mg

California Gold Nutrition
<p>A branded Boswellia extract is paired with turmeric powder and a declared curcuminoid extract, giving both core botanicals meaningful disclosed amounts. It covers the original main ingredients, although the supplied details still leave some active percentages or absorption information unclear.</p>
80 Performance

No. 7

Solgar
<p>A named 5-Loxin Boswellia extract and concentrated turmeric are joined by standardized cartilage, vitamin C, ginger, willow, and a pepper complex. It covers the original main ingredients, although the supplied details still leave some active percentages or absorption information unclear.</p>
79 Performance

High Absorption Curcumin 500 mg

Doctor's Best
<p>A large declared Curcumin C3 Complex amount is paired with piperine, making the turmeric active and absorption support easier to assess. Compared with the original, it omits boswellia, so its ingredient coverage is narrower.</p>
81 Budget

Boswellia Serrata

Swanson
<p>No eligible candidate has a lower serving cost; this is among the closest-priced choices. Boswellia powder plus a named Boswellin extract provides both boswellic-acid and organic-acid forms with disclosed amounts. Compared with the original, it omits turmeric, so its ingredient coverage is narrower.</p>
79 Budget

Turmeric 538 mg

Nature's Bounty
<p>No eligible candidate has a lower serving cost; this is among the closest-priced choices. A single turmeric extract supplies a clearly stated curcuminoid amount without a proprietary blend. Compared with the original, it omits boswellia, so its ingredient coverage is narrower.</p>
77 Budget

Turmeric

Mason Natural
<p>No eligible candidate has a lower serving cost; this is among the closest-priced choices. A simple curcuminoid formula provides a clearly stated turmeric amount, although the supplied details do not describe absorption support. Compared with the original, it omits boswellia, so its ingredient coverage is narrower.</p>
78 Value

Boswellia Resin Extract

Solgar
<p>A standardized Boswellia extract with additional Boswellia powder gives the main active form and total amount clearer definition. Its serving cost is slightly higher, so the value rests on better-defined active ingredients. Compared with the original, it omits turmeric, so its ingredient coverage is narrower.</p>
84 Value

Curcumin C3 Complex with BioPerine

California Gold Nutrition
<p>A declared total-curcuminoid extract with piperine provides a concise, well-defined turmeric formula. Its serving cost is slightly higher, so the value rests on better-defined active ingredients. Compared with the original, it omits boswellia, so its ingredient coverage is narrower.</p>
83 Value

Turmeric Curcumin 500 mg

SR Sports Research
<p>A named Curcumin C3 Complex amount with black-pepper extract offers concentrated turmeric support with clear doses. Its serving cost is slightly higher, so the value rests on better-defined active ingredients. Compared with the original, it omits boswellia, so its ingredient coverage is narrower.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  3. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  4. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  5. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  6. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  7. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  8. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  9. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  10. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  11. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia